C. Astariedequeker et al., INHIBITORY EFFECT OF TRIMETAZIDINE ON THROMBIN-INDUCED AGGREGATION AND CALCIUM-ENTRY INTO HUMAN PLATELETS, Journal of cardiovascular pharmacology, 23(3), 1994, pp. 401-407
The antiaggregatory properties of trimetazidine were investigated furt
her by analyzing its effects on cytosolic calcium and proton concentra
tions, well-known regulators of platelet reactivity. Aggregatory respo
nses of washed platelets were assessed by turbidometry, and cytosolic
Ca2+ concentration ([Ca2+]i) and pH (pHi) were determined by their res
pective fluorescent probes: Fura-2 and BCECF. Preincubation with trime
tazidine dose-dependently inhibited platelet aggregation induced by 0.
05 U/ml thrombin (p < 0.001). At concentrations less than or equal to
1 mM, trimetazidine did not affect the resting [Ca2+]i value but sligh
tly alkalinized the cytosol by 0.05 +/- 0.03 pH units (p < 0.02, n = 1
1). In platelets stimulated by 0.05 U/ml thrombin, 0.1 mM trimetazidin
e did not modify pHi variations but decreased [Ca2+]i variations (p <
0.003, n = 16), blunting by 28 +/- 6% the transient peak of [Ca2+]i (p
< 0.006) and decreasing by 6 +/- 2% the equilibrium value (p < 0.005)
. These inhibitory effects were inversely dependent on thrombin concen
trations (p < 0.004, n = 21) and were abolished in the virtual absence
of external Ca2+. Trimetazidine therefore attenuates the Ca2+ influx
evoked by thrombin, thereby limiting Ca2+ accumulation in stimulated p
latelets. Such a protective effect may participate in the antiaggregat
ory properties of trimetazidine.